中基健康(000972) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was 0.00, a decrease of 100.00% compared to 2,758,230.08 in the same period last year[8] - The net profit attributable to shareholders was -19,979,751.27, representing an increase of 53.21% from -13,041,004.34 year-on-year[8] - The basic earnings per share were -0.0259, a decline of 53.25% from -0.0169 in the same period last year[8] - The total profit loss increased by 53.13% to ¥-19,988,180.25 compared to ¥-13,053,465.20 in the previous year, reflecting the ongoing transformation and production halt[15] - The net profit for Q1 2021 was a loss of CNY 19,988,180.25, compared to a loss of CNY 13,053,465.20 in the same period last year, indicating an increase in losses of about 53.5%[39] - The total operating costs for Q1 2021 were CNY 20,017,428.02, an increase from CNY 15,920,524.82 in the previous year, representing a growth of approximately 25.8%[38] Cash Flow and Liquidity - The net cash flow from operating activities was -25,390,802.51, an increase of 430.00% compared to -4,790,684.39 in the previous year[8] - The cash inflow from operating activities totaled CNY 149,553.82 in Q1 2021, a decrease from CNY 733,296.72 in the previous year[45] - Total cash outflow from operating activities amounted to 25,540,356.33 CNY, while cash inflow was only 1,581,660.56 CNY, resulting in a negative cash flow situation[49] - The ending cash and cash equivalents balance decreased to 10,548,551.53 CNY from 37,016,403.17 CNY at the beginning of the period, indicating a cash depletion of 26,467,851.64 CNY[47] - The company’s cash and cash equivalents decreased significantly from CNY 366,012.44 to CNY 16,884.87, a decline of approximately 95.4%[32] - The company’s cash and cash equivalents decreased by 71.32% to ¥10,613,891.89 from ¥37,007,442.78 due to a transformation and production halt[15] Assets and Liabilities - The total assets at the end of the reporting period were 562,832,228.58, down 3.38% from 582,505,841.85 at the end of the previous year[8] - The total liabilities increased slightly from CNY 401,294,652.22 to CNY 401,609,219.20, an increase of about 0.8%[31] - The company’s total equity decreased from CNY 181,211,189.63 to CNY 161,223,009.38, a decline of approximately 11%[32] - The total current liabilities increased from CNY 245,683,431.85 to CNY 245,963,265.50, an increase of about 0.1%[31] - The total non-current assets slightly increased from CNY 361,212,417.84 to CNY 362,306,880.74, an increase of about 0.3%[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 33,156[10] - The top shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 16.18% of shares[10] Operational Changes - The company is currently undergoing a transformation and production halt, impacting all major financial metrics significantly[15] - Management expenses increased by 63.99% to ¥18,666,259.97, attributed to fixed asset depreciation[15] - The company reported no non-recurring gains or losses during the reporting period[8] - The company did not report any cash inflow from investment activities, highlighting a lack of investment recovery during the quarter[50] - The company reported a credit impairment loss of CNY 25,000.00 in Q1 2021, compared to no such loss in the previous year[38] Tax and Financial Expenses - The company reported a 260.97% increase in tax payments to ¥9,401,699.46, due to tax liabilities from December 2020[17] - The financial expenses for Q1 2021 were CNY 1,345,108.05, up from CNY 1,072,145.61 in the previous year, indicating an increase of about 25.3%[38]